3192 results for «964»

Filter By

3192 results

These EuroIntervention papers changed my practice!

15 May 2024 – From EuroPCR 2024

These EuroIntervention papers changed my practice!

Bifurcation lesion, interactive case discussion

15 May 2024 – From EuroPCR 2024

Bifurcation lesion, interactive case discussion

Technical pearls in CTO PCI

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the technical pearls and innovative approaches in the management of chronic total occlusions (CTO) during percutaneous coronary interventions. Attendees will have the opportunity to explore various strategies, including the use...

Technical pearls in CTO PCI

The turning point in hypertension care: Symplicity Spyral renal denervation in practice

15 May 2024 – From EuroPCR 2024

Explore this session to grasp the FDA-approved status of renal denervation, its safety and efficacy shown in numerous studies with lasting effects, and the importance of multidisciplinary discussions for successful indications. Consult also the session for updated recommendations on renal denervation in hypertension treatment guidelines, procedural safety...

The turning point in hypertension care: Symplicity Spyral renal denervation in practice

Innovations in TMVR and Intrepid trial updates

14 May 2024 – From EuroPCR 2024

Tune in to this session for comprehensive updates on APOLLO and Intrepid TF, along with invaluable lessons gleaned. Discover insights on patient screening for Intrepid TMVR, and delve into clinical case reviews highlighting advancements such as updated 29Fr access. Learn about the safety and efficacy of...

Innovations in TMVR and Intrepid trial updates

Role of deferred stenting in culprit and non-culprit lesions for STEMI

14 May 2024 – From EuroPCR 2024

This session explores the role of deferred stenting in STEMI patients, covering when and how PCI can be deferred, the latest pharmacological options for deferred stenting, and the use of imaging and physiology to guide revascularization in a primary PCI setting. Through case presentations and discussions,...

Role of deferred stenting in culprit and non-culprit lesions for STEMI

COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V)

18 Feb 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the Sputnik V vaccine

Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial

31 Aug 2021

Luigi Biasco reports the best of Dj Lakkireddy (Overland Park, USA)'s presentation of the AMULET IDE trial at the Monday, August 30 Hot Line session of the ESC Congress 2021.

Luigi Biasco

Author

Luigi Biasco
ESC Congress 2021 - Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Luigi Biasco

Author

Luigi Biasco
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut low risk Trial

Portico with FlexNav TAVI system: enhancing innovative technology to optimize patient outcomes and physician experience

05 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Transfemoral TAVI in the horizontal aorta

12 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Transfemoral TAVI in the horizontal aorta

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
Didn’t find what you were looking for?